Kidney cancer and diabetes mellitus: a population-based case-control study in Taiwan.
- Author:
Shih Wei LAI
1
;
Kuan Fu LIAO
;
Hsueh Chou LAI
;
Pang Yao TSAI
;
Fung Chang SUNG
;
Pei Chun CHEN
Author Information
- Publication Type:Journal Article
- MeSH: Carcinoma, Renal Cell; etiology; Case-Control Studies; Diabetes Complications; Female; Humans; Hypoglycemic Agents; therapeutic use; Kidney Neoplasms; etiology; Male; Middle Aged; Risk Factors
- From:Annals of the Academy of Medicine, Singapore 2013;42(3):120-124
- CountrySingapore
- Language:English
-
Abstract:
INTRODUCTIONThe purpose of this study was to explore whether diabetes mellitus (DM) correlates with the risk of kidney cancer in Taiwan.
MATERIALS AND METHODSWe designed a population-based case-control study from the Taiwan National Health Insurance Database, which consisted of 116 patients with newly diagnosed kidney cancer as cases and 464 subjects without kidney cancer as controls in 2000 to 2009. Both cases and controls were aged ≥20 years. Baseline comorbidities were compared between kidney cancer cases and controls.
RESULTSMultivariable analysis showed no association was detected between DM and kidney cancer (OR 1.06, 95% CI, 0.58 to 1.94). Hypertension (OR 2.05, 95% CI, 1.23 to 3.42), chronic kidney diseases (OR 2.57, 95% CI, 1.23 to 5.37), cystic kidney diseases (OR 18.6, 95% CI, 1.84 to 187.6) and kidney stones (OR 4.02, 95% CI, 2.43 to 6.66) were significant comorbidities associated with increased risk of kidney cancer. Use of alpha-glucosidase inhibitor was associated with increased risk of kidney cancer (OR 4.31, 95% CI, 1.07 to 17.3).
CONCLUSIONDM does not correlate with the risk of kidney cancer. Hypertension, chronic kidney diseases, cystic kidney diseases, kidney stones and use of alpha-glucosidase inhibitors are associated with kidney cancer.
